Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))
原理
VEGF-C antibody
特异性
Recombinant human VEGF-C
交叉反应
大鼠
交叉反应 (详细)
This antibody detects human and rat VEGF-C in Western blots. No cross-reactivity is shown with VEGF-A.
产品特性
Chromosomal location: 11q13 This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with recombinant human VEGF-C recombinant protein).
纯化方法
The IgG2a fraction of culture supernatant was purified by Protein G affinity chromatography.
Western Blot: Use at 1-5 μg/mL, IHC: Use at 2-10 μg/mL
限制
仅限研究用
状态
Lyophilized
溶解方式
Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
缓冲液
PBS
注意事项
Centrifuge vial prior to opening.
储存条件
4 °C,-20 °C
储存方法
The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
有效期
24 months
抗原
VEGFC
(Vascular Endothelial Growth Factor C (VEGFC))
Vascular endothelial growth factor C, VEGFC, VRP, Flt4-L,VEGF-C, also known as Vascular Endothelial Growth Factor Related Protein (VRP), is a recently discovered VEGF growth factor family member that is most closely related to VEGF-D. The human VEGF-C cDNA encodes a pre-pro-protein of 416 amino acids residues. It is almost identical to the mouse VEGF-C protein. Similar to VEGF-D, VEGF-C has a VEGF homology domain spanning the middle third of the precursor molecule and long N- and C-terminal extensions. In adults, VEGF-C is highly expressed in heart, placenta, ovary and small intestine. Recombinant human VEGF-C, lacking the N- and C-terminal extensions and containing only the middle VEGF homology domain, forms primarily non-covalently linked dimers. This protein is a ligand for both VEGFR-2/KDR and VEGFR-3/FLT-4. Since VEGFR-3 is strongly expressed in lymphatic endothelial cells, it has been postulated that VEGF-C is involved in the regulation of the growth and/or differentiation of lymphatic endothelium. Although recombinant human VEGF-C is also a mitogen for vascular endothelial cells, it is much less potent than VEGF-A. The recombinant human VEGF-C contains 115 amino acids residues and was fused to a His-tag (6x His) at the C-terminal end. As a result of glycosylation VEGF-C migrates as an 18-24 kDa protein in SDS-PAGE under reducing conditions.